Norwegian (OSEAX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jun 23, 2026

Discover Norwegian Pharmaceuticals & Biotech Growth Stocks that are on the OSEAX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NAVA	NOK 16.70	-0.3%	-20.5%	NOK 394.5m	NOK 26.00	1.3	105.5%	n/a
AZT	NOK 20.10	-0.5%	21.1%	NOK 1.0b	NOK 31.00	76.4	46.0%	n/a
NYKD	NOK 3.22	2.2%	80.7%	NOK 1.0b	NOK 5.00	195.1	27.0%	28.8%
TRMED	NOK 4.20	0.2%	63.9%	NOK 1.5b	NOK 3.50	1806.9	26.0%	n/a
ONCIN	NOK 49.00	11.9%	n/a	NOK 223.9m	NOK 59.50	7.8	20.9%	n/a
PHO	NOK 60.00	1.7%	13.2%	NOK 1.6b	NOK 84.00	18.9	-20.7%	n/a
LYTIX	NOK 9.30	4.5%	-4.9%	NOK 707.5m	NOK 15.00	11.6	-25.2%	n/a
CRNA	NOK 8.35	2.3%	1,204.7%	NOK 1.8b	n/a	-43.3	n/a	n/a
EXTX	NOK 0.77	-8.9%	-70.6%	NOK 53.8m	n/a	825.6	n/a	n/a
VISTN	NOK 20.50	0%	-14.9%	NOK 909.1m	n/a	12.2	n/a	7.3%
NORD	NOK 86.40	0%	n/a	NOK 443.4m	n/a	3.5	n/a	30.1%
ZLNA	NOK 19.00	-7.3%	39.8%	NOK 491.2m	n/a	62390.8	n/a	n/a
HBC	NOK 1.25	6.4%	-33.5%	NOK 509.7m	n/a	2.0	n/a	n/a
ABS	NOK 3.30	-3.8%	-5.4%	NOK 87.6m	n/a	2.1	n/a	n/a
SOFTX	NOK 0.11	-1.3%	25.3%	NOK 282.1m	n/a	18.0	n/a	n/a

Page 1 of 1